2008

The GDG are grateful to Bernard Higgins, Jane Ingham, Ian Lockhart, Jill Parnham, Nicole Stack, Susan Tann and Claire Turner of the NCC-CC for their support throughout the development of the guideline. The GDG would especially like to record their gratitude for the great amount of work voluntarily given to the refinement of the economic model of non-steroidal anti-inflammatory drugs by Dr Joanne Lord of the National Institute for Health and Care Excellence. The GDG would also like to thank the following individuals for giving their time to advise us on the design and interpretation of the economic model:

• Dr Phil Alderson, National Institute for Health and Care Excellence
• Mr Garry Barton, School of Economics, University of Nottingham
• Professor Chris Hawkey, Institute of Clinical Research, University of Nottingham
• Professor Tom MacDonald, Hypertension Research Centre & Medicines Monitoring Unit, University of Dundee
• Dr Jayne Spink, National Institute for Health and Care Excellence
• Dr Rafe Suvarna, Medicines and Healthcare Regulatory Agency
• Professor Richard Thomson, Professor of Epidemiology and Public Health, University of Newcastle upon Tyne
• Dr Weiya Zhang, Associate Professor, Centre for Population Sciences, University of Nottingham

2014

The GDG are grateful to Hati Zorba, Tamara Diaz, Katie Jones, Serena Carville, David Wonderling, Professor Nigel Arden, Professor Martin Underwood, Professor Mark Baker, Ben Doak and Dr Martin Allaby, for their support throughout the development of the guideline.